Retinoic acid is essential for skin growth and differentiation and its concentration in skin is tightly controlled. In humans, four different members of the short-chain dehydrogenase/ reductase (SDR)* superfamily of proteins were proposed to catalyze the rate-limiting step in the biosynthesis of retinoic acid, the oxidation of retinol to retinaldehyde. Epidermis contains at least three of these enzymes but their relative importance for retinoic acid biosynthesis and regulation of gene expression during growth and differentiation of epidermis is not known. Here, we investigated the effect of the four human SDRs on retinoic acid biosynthesis and their impact on growth and differentiation of keratinocytes using organotypic skin raft culture model of human epidermis. The results of this study demonstrate that ectopic expression of Retinol Dehydrogenase 10 (RDH10, SDR16C4) in skin rafts dramatically increases proliferation and inhibits differentiation of keratinocytes, consistent with the increased steady-state levels of retinoic acid and activation of retinoic acid-inducible genes in RDH10 rafts. In contrast, SDRs with dual retinol/sterol substrate specificity, namely Retinol Dehydrogenase 4 (RoDH4, SDR9C8), RoDH-like 3α-Hydroxysteroid Dehydrogenase (RL-HSD, SDR9C6), and RDH-like SDR (RDHL, SDR9C4) do not affect the expression of retinoic acid-inducible genes, but alter the expression levels of several components of extracellular matrix. These results reveal essential differences in the metabolic contribution of RDH10 versus retinol/sterol dehydrogenases to retinoic acid biosynthesis and provide the first evidence that non-retinoid metabolic products of retinol/sterol dehydrogenases affect gene expression in human epidermis.
Retinoic acid is essential for skin growth and differentiation and its concentration in skin is tightly controlled. In humans, four different members of the short-chain dehydrogenase/ reductase (SDR)* superfamily of proteins were proposed to catalyze the rate-limiting step in the biosynthesis of retinoic acid, the oxidation of retinol to retinaldehyde. Epidermis contains at least three of these enzymes but their relative importance for retinoic acid biosynthesis and regulation of gene expression during growth and differentiation of epidermis is not known. Here, we investigated the effect of the four human SDRs on retinoic acid biosynthesis and their impact on growth and differentiation of keratinocytes using organotypic skin raft culture model of human epidermis. The results of this study demonstrate that ectopic expression of Retinol Dehydrogenase 10 (RDH10, SDR16C4) in skin rafts dramatically increases proliferation and inhibits differentiation of keratinocytes, consistent with the increased steady-state levels of retinoic acid and activation of retinoic acid-inducible genes in RDH10 rafts. In contrast, SDRs with dual retinol/sterol substrate specificity, namely Retinol Dehydrogenase 4 (RoDH4, SDR9C8), RoDH-like 3α-Hydroxysteroid Dehydrogenase (RL-HSD, SDR9C6), and RDH-like SDR (RDHL, SDR9C4) do not affect the expression of retinoic acid-inducible genes, but alter the expression levels of several components of extracellular matrix. These results reveal essential differences in the metabolic contribution of RDH10 versus retinol/sterol dehydrogenases to retinoic acid biosynthesis and provide the first evidence that non-retinoid metabolic products of retinol/sterol dehydrogenases affect gene expression in human epidermis.
All-trans-retinoic acid is a small lipophilic molecule derived from vitamin A that regulates the expression of over 530 different genes in various types of cells and tissues through binding to nuclear transcription factors, retinoic acid receptors (RARs) [1] . Skin is one of the best characterized targets of retinoid action [2, 3] , and contains all the major components of retinoid signaling and metabolic machinery such as retinoid receptors RARγ and RXRα [4] ; cellular retinoic acid [5] and retinol binding proteins [6, 7] ; retinaldehyde dehydrogenases [8] ; lecithin retinol acyltransferase (LRAT) [9] ; and cytochrome P450s [10] . Keratinocytes can synthesize retinoic acid in situ from plasma-derived retinol [11] [12] [13] ; the reported concentration of retinoic acid in the epidermal cells is very low (≤20 nM), and it is strictly controlled [14] . Concentrations that exceed the optimal range suppress differentiation and promote hyperproliferation, while concentrations below this range lead to formation of orthokeratotic epithelium [15] .
Retinoic acid is synthesized from retinol in two steps: first, retinol is reversibly oxidized to retinaldehyde, and then retinaldehyde is oxidized irreversibly to retinoic acid. The oxidation of retinol to retinaldehyde is the rate-limiting step in retinoic acid biosynthesis [16] . Recent studies suggested that this step is catalyzed by the members of the short-chain dehydrogenase/ reductase (SDR) superfamily of proteins [17] (for SDR nomenclature see ref. 18 ). In humans, four different SDRs were implicated in the biosynthesis of retinoic acid. Three of these enzymes, namely retinol dehydrogenase 4 (RoDH4, SDR9C8), RoDH-like 3α-hydroxysteroid dehydrogenase (RL-HSD, SDR9C6) and RDH-like SDR (RDHL, also known as DHRS9, SDR9C4) share significant sequence similarity with one another and belong to the same branch of the SDR phylogenetic tree [18, 19] . Besides the retinol dehydrogenase activity, all three of these human enzymes exhibit high activity toward 3α-hydroxysteroids and were proposed to catalyze the back-conversion of inactive 5α-androstane-3α,17β-diol to the potent androgen dihydrotestosterone [20] , and to oxidize and inactivate the bioactive neurosteroid allopregnanolone [21] . In addition, RL-HSD was shown to exhibit a 3(α→β)-hydroxysteroid epimerase activity, converting 3α-hydroxysteroids into 3β-hydroxysteroids [22] . The fourth SDR enzyme that was shown to catalyze the oxidation of retinol for retinoic acid biosynthesis is Retinol Dehydrogenase 10 (RDH10, SDR16C4) [23, 24] . RDH10 shares little similarity with the retinol/sterol dehydrogenases (abbreviated here as RSDHs) described above and belongs to a different branch of the SDR phylogenetic tree. It is not yet known whether RDH10 is active toward hydroxysteroids or any other substrates besides retinoids.
Data from this and other laboratories [25] [26] [27] indicate that human epidermis contains at least three of the retinoid-active SDRs. However, their relative roles in the biosynthesis of retinoic acid and regulation of gene expression are not known. In part, this is due to technical difficulties associated with analyzing functions of enzymes that are expressed at very low levels in human cell lines and tissues and their generally low enzymatic activity. Furthermore, the use of mouse models has been limited by the redundancy of RoDH-like SDR homologs in mice and the lack of orthologs for some of the human genes [19] . In this study, we took advantage of the ex vivo human organotypic skin culture in order to examine the contribution of human SDRs to retinoic acid biosynthesis and their impact on gene expression.
Human organotypic skin culture is very similar to human skin in its morphology and metabolism, because human foreskin keratinocytes are grown at the liquid-air interface, a system that recreates fully differentiated squamous epithelium [28] . Keratinocytes placed on top of the collagen bed receive moisture and nutrients through the support matrix, growing upwards and forming a "raft" culture. The keratinocytes in this "raft" culture proliferate, stratify, differentiate, and form layers just like normal skin. Importantly, this model recreates the complex process of epidermal differentiation that involves the temporal and spatial regulation of a large number of key molecules [29] ; gene expression pattern in "raft" cultures is very similar to that seen in whole foreskin [30, 31] . The genetic make-up of skin raft culture can be manipulated using retrovirusmediated gene expression. This aspect of skin raft culture model was utilized in the present study in order to investigate the individual contribution of the four human SDR enzymes to the biosynthesis of retinoic acid and regulation of gene expression during the growth and differentiation of human epidermis. The results of this study reveal important differences in the physiological roles of the four human SDRs.
EXPERIMENTAL PROCEDURES
Retroviral Vectors-The cDNAs encoding human RDH10, RoDH4, RL-HSD, and RDHL were PCRamplified from previously described clones using the primers containing BamHI and EcoRI restriction sites. Sequences of primers are as follows. For RDH10, 5′-GTG GAT CCA TGA  ACA TCG TGG TGG AGT TCT TCG-3′  (forward), 5′-GAG AAT TCA GAT TCT TAG  ATT CCA TTT TTT GCT TCA T-3′ (reverse); for  RL-HSD, 5′-ATC GGA TCC ATG TGG CTC  TAC CTG GCA GCC T-3′ (forward); 5′-ATC  GAA TTC TTA GAC TGC CTG GGC TGG TTT  GG-3′ (reverse); for RDHL, 5′-ATC GGA TCC  ATG CTC TTT TGG GTG CTA GGC CT-3′  (forward), 5′-ATC GAA TTC TCA CAC TGC  CTT GGG ATT AGC C-3′ (reverse); for RoDH4,  5′-ATC GGA TCC ATG TGG CTC TAC CTG  GCG GTT TTC-3′ (forward), 5′-ATC GAA TTC  TCA TAG AGC CTT GGC CGG GCT TG-3' (reverse). The PCR products were digested with BamHI and EcoRI endonucleases and cloned into the corresponding sites of Moloney Murine Leukemia retroviral vector pBabe puro under the control of the retroviral long terminal repeat (LTR) promoter. All of the constructs were verified by sequencing. by electroporation. Culture media from electroporated cells containing ecotropic retroviruses were used to infect GP+envAM12 cells (ATCC, Manassas, VA), an NIH3T3-derived amphotropic packaging cell line. Twenty-four hours after infection, the cells were placed into selection medium containing 1 µg/ml puromycin for 6 days. The resistant cells were allowed to reach confluence in order to obtain high titer retroviruses. The retrovirus-containing media from the producer cells was used to infect primary human keratinocytes (PHKs) [32] .
Preparation of Transgenic Organotypic Skin
Rafts-Neonatal foreskins were obtained from the Newborn Nursery of the University of Alabama at Birmingham Hospital in compliance with University of Alabama at Birmingham Institutional Review Board regulations. Epidermal raft cultures were prepared as described previously [32] . Briefly, PHKs were isolated from freshly collected neonatal foreskins and cultured in DermaLife Calcium-Free medium (Lifeline Cell Technology, Walkersville, MD). Freshly collected retrovirus-containing media from producer cells were used to infect PHKs. Infected PHKs were selected with 1.5 µg/ml puromycin for 2 days and then cultured in DermaLife Calcium-Free medium until confluency. Retrovirus-transduced PHKs (4 × 10 5 cells/ml) were seeded onto a dermal equivalent consisting of collagen with embedded Swiss 3T3 J2 fibroblasts (kindly provided by Dr. Louise T. Chow, Department of Biochemistry and Molecular Genetics, University of AL-Birmingham) and cultured submerged for several days. After three days, skin equivalents were lifted onto stainless steel grids, and cultured at the medium-air interface using raft culture medium prepared from Dulbecco's modified Eagle's medium, Ham's F12, and bovine fetal serum, which was supplemented with cholera toxin, insulin, apo-transferrin, hydrocortisone-21, and human epidermal growth factor as described previously [32] . The raft cultures were allowed to stratify and differentiate for 10-11 days, whereupon they were harvested for analysis. Twelve hours before harvest, the medium was supplemented with bromodeoxyuridine (BrdU) (50 µg/ml) to mark cells in S phase. The rafts were harvested, fixed in 10% buffered formalin and embedded in paraffin. Alternatively, epithelial tissues were manually separated from the collagen bed and used for protein extraction.
Immunohistochemistry and H&E stainingParaffin-embedded skin rafts were cut into 5 µm sections, mounted on Superfrost/Plus slides (Fisher Scientific, Pittsburgh, PA), then deparaffinized and rehydrated by a series of washes in containers with decreasing concentrations of ethanol (95%, 85%, 70%, 50%, and 30%). For H&E staining, the sections were incubated with Weigert's hematoxylin (Poly Scientific, Bay Shore, NY), dehydrated through graded ethanol, re-stained with eosin (Fisher Scientific) , and mounted with Permount (Fisher Scientific) .
For immunohistochemical staining, the sections were pretreated with sodium citrate buffer (pH 6.0) at 95°C for 10 min to unmask antigens, followed by incubation in 3% hydrogen peroxide for 20 min to block endogenous peroxidase activity. The slides were then washed in phosphate-buffered saline (PBS) (pH 7.2) and incubated with primary antibodies as follows: a 1:100 dilution of BrdU antibodies (Invitrogen, Camarillo, CA); and a 1:100 dilution of filaggrin antibodies (Leica Microsytems Inc. Bannockburn, IL). After incubation with primary antibodies at 4°C overnight, samples were rinsed with PBS and re-incubated with a 1:50 dilution of biotinylated secondary antibodies (anti-rabbit, anti-mouse immunoglobulins) from the SuperSensitive LinkLabel-IHC Detection Kit manufactured by Biogenex (San Ramon, CA) for 30 min at room temperature. After washing with PBS several times, the sections were incubated for 30 min with a 1:50 dilution of streptavidin conjugated horseradish peroxidase followed by incubation with 3,3'-diaminobenzidine tetrahydrochloride (DAB) from Turbbo DAB kit (Innovex Biosciences, Richmond, CA) as the chromogenic substrate. Sections were counterstained with Weigert's hematoxylin (Polyscientific), dehydrated through graded ethanol, cleared in xylene, and mounted with Permount (Fisher Scientific). All sections were analyzed at a 20× magnification using AxioImager A2 microscope equipped with an AxioCam camera and AxioVision image capture software (Carl Zeiss MicroImaging Inc., Thornwood, NY).
Western Blotting-The epidermis from raft cultures was peeled off collagen beds and homogenized on ice in PBS with 20% glycerol containing a mixture of protease inhibitors: aprotinin (1 µg/ml), leupeptin (1 µg/ml), pepstatin-A (1 µg/ml), and phenylmethylsulfonyl fluoride (50 µg/ml). Lysates were cleared by centrifugation at 16,100 g for 15 min at 4°C. Protein concentrations were quantified using Bio-Rad DC protein assay (Bio-Rad Laboratories, Hercules, CA). Samples were resolved by electrophoresis in 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane for subsequent probing with polyclonal antibodies against RoDH4 (1:5,000 dilution) [33] , RL-HSD (1:5,000 dilution) [34] , RDHL (1:5000 dilution) [21] , or with affinity purified polyclonal antibody against RDH10 (1:500 dilution) [24] in conjunction with the appropriate horseradish peroxidase (HRP)-conjugated secondary antibody and ECL enhanced chemiluminescence detection system (GE Healthcare, Piscataway, NJ). Gel loading was determined by reprobing with HRP-conjugated monoclonal β-actin antibody (1:5,000; SigmaAldrich).
Activity Assays-Organotypic cultures of PHKs expressing RDH10, RoDH4, RL-HSD and RDHL were prepared essentially as described above with minor modifications. Retrovirus-transduced PHKs (4 × 10 5 cells/ml) were seeded onto Costar transwells (Corning Life Sciences, Lowell, MA), which were placed into 24-well plates and cultured submerged for several days. At confluency, transwells containing PHKs were transferred onto dermal equivalents, and skin rafts were cultured as described above. For analysis of retinoid metabolism, culture medium was supplemented with 2 µM all-trans-retinol under reduced light twenty-four hours before harvest. Rafts were peeled off transwells and homogenized in PBS on ice. Culture media were collected separately. All manipulations were done under reduced light. Retinoids were extracted into hexane and separated by reversed phase high performance liquid chromatography (HPLC) using Waters Alliance Separation Module and 2996 Photodiode Array Detector [35] . Chromatographic peaks were identified by comparing retention times and spectra against retinoid standards and quantified as described previously [36] . Total retinoids were normalized by tissue weight and protein amount.
For steroid activity assays, commercially available radiolabeled steroids (PerkinElmer Life Sciences; ~40-60 Ci/mmol each) were diluted with cold steroids (Steraloids Inc. Newport, RI) dissolved in dimethyl sulfoxide (Me 2 SO). For analysis of activities in raft cultures, steroid stock solutions were added to skin raft culture medium containing fetal bovine serum. Steroid reference standards were generated by incubating Sf9 microsomes expressing RL-HSD with androsterone (ADT) or allopregnanolone (ALLO) in phosphate buffer (90 mM KH 2 PO 4 , 40 mM KCl, pH 7.4) containing fatty acid-free bovine serum albumin (BSA) equimolar to steroids as described previously [34] .
After 24-hour incubation, media and cells were collected separately as described above and extracted with 7 volumes of dichloromethane. The organic layer was evaporated under a stream of nitrogen and dissolved in 50 µl of fresh dichloromethane. Steroids were separated by development in toluene:acetone (4:1) on silica gel thin-layer chromatography (TLC) plates (SigmaAldrich, St. Louis, MO). TLC plates containing 3 H-labeled steroids were exposed to PhosphorImager tritium screen (GE Healthcare Life Sciences, Piscataway, NJ) overnight, and the intensity of the bands was calculated using ImageQuant 5.0 program. Products of each reaction were identified by comparison to reference steroids [34] .
LC/MS-MRM Analysis-Samples were separated by gradient reversed phase high performance liquid chromatography. The gradient was generated with a Shimadzu Prominence UFLC system consisting of a vacuum degasser, binary pump, and a temperature controlled autosampler. The injection volume was 80 µL and the samples were maintained in the autosampler at 4° C. The column was a Develosil RP Aqueous 2.00 mm i.d. All gases were nitrogen.
Q-PCR-RNA from rafts was isolated using Trizol reagent (Invitrogen). First-strand cDNA was synthesized using SuperScript III kit (Invitrogen). cDNA was purified using miniprep DNA purification kit (Qiagen). Real-time PCR was performed in LightCycler® 480 instrument (Roche) using LightCycler® 480 SYBR Green I Master Mix (Roche) with 0.5 µM primers and 2.5-25 ng of purified cDNA per reaction. Sequences of the primers are available by request. Levels of transcripts were determined using relative quantification method [37] . Three empty vectortransduced and three SDR-expressing rafts were included in each qPCR experiment. To evaluate the significance of differences in expression levels of each transcript between control and SDRexpressing rafts, an unpaired t-test was performed and two-tailed p-value was determined using GraphPad InStat version 3.00 (GraphPad Software, San Diego California USA, www.graphpad.com).
RESULTS

Expression of Human SDRs in Transgenic Skin
Rafts-Previous studies have indicated that the retinoid-active SDRs are naturally expressed in human skin [25] [26] [27] , suggesting that skin organotypic culture is a physiologically relevant model for analyzing functions of these enzymes. We have confirmed the presence of RoDH4, RDHL, and RDH10 transcripts in human organotypic raft cultures by RT-PCR (Supplemental Fig. 1) . However, the protein levels of most of these enzymes were below detection limit by Western blotting (Fig. 1) . Therefore, we examined their functions by increasing the levels of individual proteins through retrovirus-mediated ectopic expression of the corresponding cDNAs. PHKs from neonatal foreskin infected with retroviruses were plated on a collagen-fibroblast matrix, and then lifted to the air-liquid interface to generate stratified and differentiated epithelium. To confirm the ectopic expression of the SDRs, epidermis was manually separated from collagen beds and processed for immunoblotting. As shown in Figure 1 , protein levels of RDH10, RoDH4, and RL-HSD, which were below detection limit by available antisera in skin rafts infected with empty virus (Fig. 1 A, B and C) , increased significantly following transduction with the corresponding recombinant retroviruses. The levels of RDHL protein, which was visible in mock-transduced rafts, increased further in transgenic skin infected with RDHL-expressing retrovirus (Fig. 1 D) . This analysis confirmed successful expression of the SDR proteins in transgenic skin.
Histological Analysis of Skin Rafts-As PHKs proliferated and formed stratified epithelium, significant differences were noted in the appearance of rafts expressing RDH10 compared to other rafts. RDH10 rafts appeared to be softer and more transparent than mock-transduced rafts or rafts expressing RoDH4, RL-HSD, or RDHL. To evaluate the morphology of transgenic epidermis, rafts were sectioned and stained with H&E. This analysis revealed striking differences in the histology of RDH10 rafts compared to other rafts (Fig. 2) . RoDH4, RL-HSD, RDHL and mock-transduced rafts had a well-developed histological appearance with clearly visible spinous, granular and cornified layers. In contrast, the granular layer in RDH10 rafts was poorly developed, and the cornified layer was much thinner than in control cultures or completely absent. Extending the time of RDH10 rafts in culture from 11 to 16 days did not produce a more differentiated epidermis (data not shown), indicating that the differentiation was not simply delayed but was profoundly impaired. Immunohistochemical staining for BrdU incorporation revealed increased proliferation of basal cells in RDH10 rafts (Fig. 2) . Furthermore, the expression of keratinocyte differentiation marker filaggrin, which was detected in a continuous band in the granular layer of RSDH rafts and mock-transduced rafts, was severely reduced or completely absent in RDH10 rafts (Fig.  2) , indicating an overall inhibition of keratinocyte differentiation and stratification/cornification of the epidermis.
Analysis of Retinoic Acid Responsive Genes-
Retinoic acid is known to induce proliferation of basal keratinocytes and to inhibit their differentiation [2, 3] . To determine whether the abnormal differentiation pattern in RDH10 rafts was associated with up-regulation of retinoic acidresponsive genes, we carried out quantitative RT-PCR analysis of several well-known targets of retinoic acid such as STRA6, RARβ, LRAT, CRBP1, CRABP2, DHRS3, and CYP26A1. This analysis revealed significant up-regulation of these genes in RDH10 rafts (Fig. 3 A) . A corresponding increase in protein levels was confirmed by Western blot analysis for CRBP1 and DHRS3 (Fig. 3 B) . In contrast, the retinoic acid-responsive genes were not up-regulated in skin rafts expressing RoDH4, RL-HSD or RDHL (Fig. 3 A) . This result suggested that an increase in the steady-state levels of retinoic acid occurred in RDH10 rafts, but not in the rafts expressing RoDH4, RL-HSD or RDHL enzymes.
Analysis of Retinoic Acid Production-To examine retinoic acid biosynthesis in RDH10 rafts versus mock-infected rafts, epidermis was grown in transwell inserts in order to exclude the contribution of collagen-embedded fibroblasts to the metabolism of retinol. Prior to the addition of retinol, transwell inserts with stratified epidermis were lifted off collagen beds and placed into multiwell culture plates containing medium supplemented with retinol or vehicle. After an overnight incubation, the rafts were peeled off transwells, homogenized and extracted for HPLC analysis following the protocol designed to maximize the yield of retinoic acid [38] . This analysis revealed that RDH10 rafts that were grown in regular culture medium and did not receive additional retinol contained a peak that was not detectable in control rafts (Fig. 4 A) and had a retention time and spectral properties identical to those of all-trans-retinoic acid (Fig. 4 B peak 2, inset 2, and C). Another peak detected in RDH10 rafts but not in control rafts had spectral properties of all-trans-3.4-didehydro-retinoic acid (Fig. 4 B, peak 1, inset 1) [39] . The presence of all-trans-3.4-didehydro-retinoic acid in skin epidermis is consistent with the previous reports [40] [41] [42] ; however, a conclusive identification of this peak was not possible in the absence of commercially available all-trans-3.4-didehydroretinoic acid standard.
The identity of the peak that had the retention time and spectral properties of all-trans-retinoic acid was examined further by LC/MS-MRM analysis. Three fragment ions that had the highest signal to noise ratio in MRM analysis were selected to monitor all-trans-retinoic acid. As shown in Fig. 4 D, the three mass transitions eluted at the same retention time and in approximately the same ratio for both the retinoic acid standard and the RDH10 skin raft sample, confirming the presence of all-trans-retinoic acid in RDH10 rafts.
The amount of endogenous all-trans-retinoic acid in RDH10 rafts grown in regular medium was estimated to be ~0.15 pmol/mg cellular protein.
An overnight incubation in medium supplemented with 2 µM retinol resulted in further increase in the amount of retinoic acid in RDH10 rafts (up to 0.52 pmol/mg cellular protein) but not in control rafts. This end-point activity assay demonstrated that RDH10 was catalytically active toward retinol and that overexpression of RDH10 resulted in the overall increase in the steady-state levels of retinoic acid, consistent with the up-regulation of retinoic acid-responsive genes.
Activity Assays with 3α-Hydroxysteroids-To exclude the possibility that the lack of upregulation of retinoic acid target genes in RSDH rafts was due to the lack of catalytic activity of recombinant RoDH4, RL-HSD and RDHL proteins, we incubated the respective skin rafts with 3α-hydroxysteroids, the alternative substrates recognized by these enzymes. Androsterone (ADT) was added to the media of RoDH4 and RL-HSD rafts, since this is the preferred 3α-hydroxysteroid substrate for RoDH4 and RL-HSD enzymes [33, 34] , whereas RDHL rafts were incubated with allopregnanolone (ALLO), which is a better substrate for RDHL [21] . RDH10 rafts were included in this experiment to determine whether RDH10 exhibits a 3α-hydroxysteroid dehydrogenase activity similarly to the three other SDRs.
TLC analysis of the reaction products demonstrated that RDH10 was inactive toward androsterone, but skin rafts expressing RoDH4 and RL-HSD efficiently converted ADT to 5α-androstanedione (5α-dione) and epiandrosterone (Fig. 5) . The formation of epiandrosterone in RL-HSD skin rafts was in agreement with the previously described 3(α→β)-hydroxysteroid epimerase activity of RL-HSD [22] . As expected, RoDH4 converted ADT to 5α-dione, which was further reduced to epiandrosterone by the endogenous 3β-ketosteroid reductase activity described by us previously [22] . RDHL rafts showed increased conversion of ALLO to 5α-dihydroprogesterone (5α-DHP) (12% versus 9% in mock-transduced rafts) and epiallopregnanolone (18% versus 15% conversion), also consistent with the previous report [21] . These experiments demonstrated that all three retinol/sterol dehydrogenases expressed in skin rafts were catalytically active.
Gene Expression and Morphology of Rafts treated
with Retinol-RoDH4 and RL-HSD both exhibit higher K m values for all-trans-retinol than RDH10 [24, 34, 43] . To test a possibility that RoDH4, RL-HSD, and RDHL could contribute to retinoic acid production at a higher concentration of retinol than that provided by the standard medium, we grew skin rafts transduced with each of the four SDRs as well as control rafts in medium supplemented with 2 µM retinol. Interestingly, supplementation with retinol resulted in epithelial morphology very similar to that observed for RDH10 rafts that were grown in regular medium (Fig. 6) , suggesting that the additional retinol was efficiently utilized by the endogenous retinol dehydrogenase(s) present in the original PHKs, resulting in increased levels of retinoic acid. This was further confirmed by q-PCR analysis, which showed significant induction of retinoic acid-responsive genes in all rafts grown in the presence of additional retinol including rafts infected with empty virus (Fig. 7, upper panel) . However, importantly, the rafts expressing RoDH4, RL-HSD, or RDHL did not show any greater up-regulation of retinoic acid-responsive genes than mock-transduced rafts (data not shown), as would be expected if these enzymes could function as retinol dehydrogenases at higher concentrations of retinol. On the other hand, RDH10 rafts that were grown in the presence of additional retinol showed further increase in RARβ expression compared to mock-transduced rafts (Fig. 7, lower panel) . This suggested that, while most of the retinoic acid-responsive genes reached their maximum expression levels in rafts treated with retinol, RARβ was not yet fully activated, and overexpression of RDH10 resulted in further increase in the level of retinoic acid and, consequently, in the expression level of RARβ. This result demonstrated that while RDH10 rafts responded to retinol supplementation by fully activating RARβ, neither RoDH4, nor RL-HSD, nor RDHL rafts displayed activation of retinoic acid-responsive genes over that seen in mocktransduced rafts even when provided with a higher concentration of retinol.
Identification of Novel Gene Targets for Retinol/Sterol Dehydrogenase and RDH10-
Having established that the retinol/sterol dehydrogenases are catalytically active in skin rafts but are not involved in the biosynthesis of retinoic acid, we examined whether their activities have an impact on the expression of genes other than those regulated by retinoic acid. Microarray data analysis revealed that the expression of a number of genes was altered in skin rafts expressing RoDH4, RL-HSD, or RDHL that were grown in regular skin raft culture medium. To confirm these findings, we carried out q-PCR analysis of several identified genes. As shown in Fig. 8 , protease inhibitor Kazal type 6 (SPINK6), fibroblast activation protein (FAP), and uroplakin 1B (UPK1B) were up-regulated, whereas corneodesmosin (CDSN) was slightly downregulated in RoDH4 rafts. RDHL rafts displayed statistically significant downregulation of fibronectin 1 (FN1), CDSN, and anterior gradient homolog 2 (AGR2) genes. AGR2 gene was also down-regulated in RL-HSD rafts. This analysis revealed some overlap in the genes targeted by the RSDHs, consistent with their overlapping substrate specificity.
Interestingly, several novel genes were identified as retinoic acid targets in RDH10 rafts. Mucin 21 (MUC21) and γ-aminobutyric acid (GABA) receptor subunit π (GABRP) were very strong responders with 40-fold and 28-fold increases in the levels of mRNA, respectively. FN1, AGR2, and periostin (POSTN) were upregulated 2-4-fold, whereas SPINK6 and solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 (SLC7A11) were downregulated ~2-fold. The opposite changes in the expression of SPINK6 and AGR2 observed for RDH10 rafts compared to rafts expressing RoDH4 or RDHL/RL-HSD further emphasized the differences in the physiological impact of RDH10 versus RSDHs. Together, these data suggested that RDH10 and RSDHs have different metabolic substrates and different sets of target genes in human skin rafts.
DISCUSSION
Human epidermis contains several retinoidactive SDRs [25] [26] [27] ; however, their relative roles in the regulation of retinoic acid-responsive genes in skin remain unknown. Here, for the first time, we compared the contribution of individual human SDRs to retinoic acid biosynthesis and regulation of gene expression during proliferation, stratification, and differentiation of organotypic skin raft cultures.
The results of this study show that all four SDRs ectopically expressed in skin rafts are catalytically active, but RDH10 has a very different effect on skin morphology than RoDH4, RL-HSD, or RDHL. Skin rafts ectopically expressing RDH10 exhibit both greater proliferation of basal cells, as indicated by the increased incorporation of BrdU, and severe inhibition of terminal differentiation, evidenced by the reduced expression of filaggrin, the marker of terminally differentiated keratinocytes. Increased proliferation of basal cells and inhibition of terminal differentiation are the hallmark features of the effects of retinoids on epithelial morphology [2, 3] , and they are consistent with the higher steady-state levels of retinoic acid detected in RDH10 skin rafts.
In normal human skin, the level of retinoic acid is undetectable or detectable only at trace amounts although topical application of retinol produces such biological effects as epidermal thickening and an increase in expression of cellular retinoic acid binding protein type II [14] . Thus, the conversion of retinol to retinoic acid in human skin is tightly regulated [44] . Our data suggest that RDH10 is expressed in human skin at a very low level, and the results of this study highlight the importance of the low level of RDH10 by demonstrating that overexpression of RDH10 results in significant up-regulation of retinoic acid target genes and disruption of normal epithelial growth and differentiation. It is important to note that this phenotype is observed in regular raft culture medium, without supplementation with retinol, and it is consistent with the high affinity of RDH10 for retinol as a substrate (K m =0.035 µM) [24] . Thus, it is clear that the amount of RDH10 in skin rafts controls the amount of retinoic acid produced from the physiologically relevant levels of retinol.
RoDH4 and RL-HSD have lower affinities for retinol (K m values of 1.1 µM and 3.2 µM, respectively) than RDH10, which might indicate that these enzymes function as retinol dehydrogenases at higher levels of retinol. However, supplementation of the growing RoDH4, RL-HSD or RDHL skin rafts with 2 µM retinol does not lead to a greater up-regulation of retinoic acid-inducible genes in these rafts compared to that observed in mock-infected rafts, indicating that even at a higher retinol concentration, these enzymes have no effect on retinoic acid biosynthesis in the reconstructed epidermis. Together, these observations suggest that out of four candidate SDRs only RDH10 can function as a retinol dehydrogenase in human skin in vivo.
While the RSDHs do not increase the expression of retinoic acid target genes, elevated levels of these proteins in skin rafts grown in regular medium do affect the expression levels of other genes. Here, we report for the first time that the activities of RoDH4, RL-HSD and RDHL induce changes in the mRNA levels of serine protease inhibitor Kazal type 6 (SPINK6), fibroblast activation protein (FAP), uroplakin 1B (UPK1B), fibronectin 1 (FN1), anterior gradient homolog 2 (AGR2) and corneodesmosin (CDSN). The relatively small changes in the expression levels of these genes could be due to limited availability of their substrates in skin raft culture medium.
Changes in some of these transcripts are specific for certain SDRs, but other genes are affected similarly in at least two of the SDRexpressing rafts, suggesting an overlap in their gene targets. For example, the 3-fold up-regulation of FAP (also called FAPα or seprase) appears to be specific for RoDH4 rafts. FAP is a cell surface serine protease that has emerged as a marker of reactive fibroblasts in tumors, but may also play a role as a tumor suppressor [reviewed in ref. 45] .
Another gene that is up-regulated specifically in RoDH4 rafts is uroplakin 1B (UPK1B). UPK1B codes for a structural protein that is a terminal differentiation component of the mammalian bladder membrane and is the only uroplakin that is expressed in tissues other than the urothelium [reviewed in ref. 46] .
SPINK6 is significantly up-regulated in RODH4 rafts but exhibits similar upward tendency in RL-HSD and RDHL rafts. SPINK6 is induced during keratinocyte differentiation, and is thought to function as the selective inhibitor of kallikreinrelated peptidases, which play a central role in skin desquamation by cleaving corneodesmosomes [47] .
Examples of gene expression changes that overlap between at least two of RSDH rafts are the downregulation of AGR2 in rafts expressing RDHL and RL-HSD, and downregulation of CDSN in RoDH4 and RDHL rafts. AGR2 (also known as AG2, HAG-2, or GOB-4) is a protein disulfide isomerase that was shown to be essential for production of mucus [48] . Interestingly, in contrast to RSDH rafts, this gene was up-regulated in RDH10 rafts.
CDSN is an extracellular component of corneodesmosomes that is specific to desmosomes of epithelia undergoing cornification. CDSN displays adhesive properties and is sequentially proteolyzed as corneocytes migrate towards the skin surface. Deletion of Cdsn gene in mice results in desmosomal breaks at the interface between the living and cornified layers [49, 50] .
Thus, non-retinoid products of RoDH4, RDHL, and RL-HSD activities appear to regulate directly or indirectly several components of the extracellular matrix important for structural integrity, adhesion, and movement of cells. In general, rafts expressing RSDHs seem to exhibit up-regulation of genes associated with terminal differentiation of keratinocytes (e.g., SPINK6 and UPK1B) as opposed to RDH10 rafts which exhibit up-regulation of genes associated with increased proliferation.
Interestingly, microarray analysis of gene expression in RDH10 skin rafts revealed a number of previously unrecognized genes that respond to RDH10 activity and, presumably, to retinoic acid.
Mucin 21 (MUC21, also known as epiglycanin) was identified as one of the strongest responders with a 40-fold increase in expression. Mucin 21 was the first mucin associated with the malignant behavior of carcinoma cells and was later shown to prevent cell adhesion [51, 52] . The upregulation of MUC21 is consistent with the fragile nature and abnormal morphological appearance of RDH10 rafts.
The second gene highly up-regulated in RDH10 rafts is peripheral type γ-aminobutyric acid (GABA) receptor subunit π (GABRP). Although GABA is known to function primarily as an inhibitory neurotransmitter in the mature central nervous system, GABA receptors are also present in nonneural tissues, including cancer. GABRP is abundant in the uterus and was detected in breast [53, 54] and lung [55] but rarely in the brain. In agreement with our detection of GABRP expression in skin raft culture, keratinocyte growth factor and an air-liquid interface culture system were shown to significantly up-regulate the expression of GABRP mRNA and protein [55] . GABRP appears to mediate the growth-promoting effect of GABA [56] . This is consistent with the retinoic acid-induced increase in GABRP expression and proliferation of basal keratinocytes.
Among the genes negatively regulated by RDH10 activity are SPINK6, which is upregulated in RSDH rafts, and solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 (SLC7A11 or xCT). SLC7A11 gene encodes the xCT subunit of the heterodimeric x(c)(-) cystine/glutamate antiporter that was implicated in GSH-based chemoresistance because it mediates cellular uptake of cystine/cysteine for sustenance of intracellular GSH levels [57, 58] . In skin, SLC7A11 is required for melanogenesis [reviewed in ref. 59]. In contrast to RDH10 rafts, expression of SLC7A11 does not change significantly in RSDH rafts.
Thus, analysis of gene expression in RDH10 versus RSDH rafts revealed a number of important differences. First of all, the retinoic acid-inducible genes are up-regulated in RDH10 rafts but not in RSDH rafts, indicating that RDH10 but not RSDH is involved in retinoic acid biosynthesis in human epidermis. Secondly, a number of genes exhibit opposite changes in RDH10 versus RSDH rafts, suggesting that they are regulated by different biologically active metabolites. Finally, some genes exhibit similar changes in RSDH rafts, suggesting a potential overlap in the metabolic products of different RSDHs, consistent with their overlapping substrate specificity. Together, these results demonstrate that RDH10, but not RSDHs, functions as a bona fide retinol dehydrogenase in a growing and differentiating human organ and provide the first evidence that the activities of RSDHs regulate the expression of non-retinoid target genes in human epidermis. Identification of the extracellular matrix components as the major targets of RSDHs in skin should facilitate the search for the true physiological substrates of these enzymes.
57. Chintala, S., Li, W., Lamoreux, M. L., Ito, S., Wakamatsu, K., Sviderskaya, E. V., Bennett, D. C., Park, Y. M., Gahl, W. A., Huizing, M., Spritz, R. A., Ben, S., Novak, E. K., Tan, J., and Swank, R. A, Three skin rafts were peeled off collagen beds, combined, and homogenized using Dounce homogenizer. The microsomal fraction was isolated by differential centrifugation and used for Western blotting (100 µg). The loading control for the microsomal fraction was P450 reductase. Total homogenate of HEK293 cells expressing recombinant RDH10 (RDH10st) was used as a molecular weight marker for RDH10 (30 µg). B-D, total homogenates prepared from single rafts were used for Western blotting (50 µg); the loading control was β-actin. Microsomes from Sf9 cells (0.3-0.5 µg) expressing corresponding SDRs were used as markers of the molecular masses. A, Q-PCR analysis was performed on RNA isolated from three individual rafts. Control groups are represented by white bars and experimental groups are represented by grey bars. Levels of transcripts were determined using relative quantification method [24] . The two-tailed p-value was determined using GraphPad InStat version 3.00 (GraphPad Software, San Diego California USA, www.graphpad.com). Statistically significant changes are indicated by * (p-value < 0.05); ** (p-value < 0.01); or *** (p-value < 0.0001). Abbreviations are as follows: STRA6, stimulated by retinoic acid gene 6; RARβ, retinoic acid receptor beta; LRAT, lecithin retinol acyltransferase; CRBP1, cellular retinol binding protein type 1; CRABP2, cellular retinoic acid binding protein type 2; DHRS3, dehydrogenase/reductase member 3 (also known as retSDR1); CYP26B1, cytochrome P450 26B1; CYP26A1, cytochrome P450 26A1; RARγ, retinoic acid receptor gamma; PDK1, 3-phosphoinositide-dependent kinase 1. B, Western blot analysis of CRBP1 and DHRS3 expression in skin rafts transduced with empty virus (mock) and RDH10 retrovirus (RDH10). Cytosolic fractions were used for detection of CRBP1 and microsomal fractions were used for detection of DHRS3 with β-actin as the loading control for cytosol and cytochrome P450 reductase for microsomes essentially as described in Fig. 1 Skin rafts were grown for 11 days in the absence (control) or presence of additional 2 µM all-trans-retinol (retinol). Sections of paraffin-embedded rafts were analyzed by H&E staining and immunostaining for BrdU and filaggrin as described in Fig. 2 . Mock-transduced or RDH10-expressing rafts were grown in the presence of additional 2 µM retinol. Retinoic acid-inducible gene expression was analyzed by q-PCR as described in legend to Fig. 3 . Gene expression levels were compared between mock-transduced rafts grown in the absence (Mock, white bars) or presence of retinol (Mock + ROL, grey bars) (upper panel); and between mock-transduced rafts grown in the presence of retinol (Mock + ROL, white bars) and RDH10 rafts grown in the presence of retinol (RDH10 + ROL, grey bars). Statistically significant changes are indicated by * (p-value < 0.05). RALDH2, retinaldehyde dehydrogenase 2; other abbreviations are as in Fig. 3 . Note further increase in the expression of RARβ in RDH10 rafts after treatment with retinol. In contrast, skin rafts expressing RoDH4, RL-HSD, or RDHL did not exhibited increase in retinoic acid-responsive genes greater than that observed in mock-transduced rafts (data not shown). Q-PCR analysis was performed as described in legend to Fig. 3 . Control groups are represented by white bars and experimental groups are represented by grey bars. Statistically significant changes are indicated by *(p-value < 0.05) or ** (p-value < 0.01). Abbreviations are: IGFL1, IGF-like family member 1; SPINK6, serine peptidase inhibitor, Kazal type 6; THBS1, thrombospondin 1; FAP, fibroblast activation protein, alpha; POSTN, periostin, osteoblast specific factor; MUC21, mucin 21; UPK1B, uroplakin 1B; TGFBI, transforming growth factor, beta-induced, 68kDa; GABRP, gamma-aminobutyric acid (GABA) A receptor, pi; FN1, fibronectin 1; TGFBl, transforming growth factor, beta 1; AGR2, anterior gradient homolog 2 (Xenopus laevis); TOB2, transducer of ERBB2, 2; CDSN, corneodesmosin; SLC7A11, solute carrier family 7, (cationic amino acid transporter, y+ system) member 11. 
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